近年来许多国家特别是北欧国家耶尔森氏菌病(下称耶氏菌病)的发病率上升。该病常发现于肠道感染患者,仅次于沙门氏菌病。苏联耶氏菌病有上升趋势。耶氏菌病发病人数增多、临床表现多样性、多器官和系统受累、复发率高、易于转变为迁延和慢性病程、难于诊断和尚无可靠疗法等,给本病的治疗带来很大困难。耶氏菌病的治疗同其他传染病一样,应采用针对病因和发病机理为主的综合疗法。在治疗过程中要考虑到疾病临床型和病情轻重型。病因治疗可用抗生素和其他抗菌药物。 In recent years, the incidence of Yersinia disease (hereinafter referred to as Yersinia) has increased in many countries, particularly in the Nordic countries. The disease is often found in patients with intestinal infections, second only to salmonellosis. Yersinia there is an upward trend in the Soviet Union. Yersinia increased the incidence of the disease, the clinical manifestations of diversity, multiple organ and systemic involvement, high recurrence rate, easy to change into persistent and chronic disease course, difficult to diagnose and no reliable therapy, the treatment of this disease has brought great difficulties. Yersinia disease treatment, like other infectious diseases, should be used for the etiology and pathogenesis-based combination therapy. In the course of treatment to take into account the clinical and severity of the disease type. Etiological treatment available antibiotics and other antibiotics.